VIVSVIVSNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank82
5Y CAGR-55.4%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-55.4%/yr
Long-term compound
Percentile
P82
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 23.51% |
| Q3 2025 | -7.79% |
| Q2 2025 | 16.53% |
| Q1 2025 | -51.74% |
| Q4 2024 | 80.89% |
| Q3 2024 | -29.81% |
| Q2 2024 | 31.89% |
| Q1 2024 | -25.87% |
| Q4 2023 | 7.42% |
| Q3 2023 | -19.87% |
| Q2 2023 | -69.43% |
| Q1 2023 | 359.83% |
| Q4 2022 | -3.74% |
| Q3 2022 | 20.69% |
| Q2 2022 | -10.13% |
| Q1 2022 | 22.57% |
| Q4 2021 | 36.38% |
| Q3 2021 | 17.07% |
| Q2 2021 | -13.82% |
| Q1 2021 | 67.41% |
| Q4 2020 | 1335.71% |
| Q3 2020 | 0.00% |
| Q2 2020 | 100.00% |
| Q1 2020 | -188.97% |
| Q4 2019 | -89.97% |
| Q3 2019 | -62.20% |
| Q2 2019 | -13.19% |
| Q1 2019 | 16.45% |
| Q4 2018 | 18.67% |
| Q3 2018 | -5.68% |
| Q2 2018 | -14.97% |
| Q1 2018 | -0.77% |
| Q4 2017 | -18.99% |
| Q3 2017 | -1.77% |
| Q2 2017 | -9.04% |
| Q1 2017 | 10.13% |
| Q4 2016 | 10.56% |
| Q3 2016 | 2.25% |
| Q2 2016 | -2.14% |
| Q1 2016 | -0.98% |